Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Stem cells ‘could be used as an alternative to antibiotics’
"...MSCs could prove useful against antimicrobial resistance and be used as an alternative to antibiotics.”

Study finds MSCs in horses fight bacterial infection 

Stem cells found in horses naturally produce molecules that can fight bacterial infection, according to new research by the Roslin Institute.

The team examined mesenchymal stem cells (MSCs), which are seen in animals and humans and can differentiate into a variety of cell types.

They discovered that MSCs may be able to fight infection in two ways - by acting directly on bacteria and by regulating the activity of immune cells involved in the body’s natural defences.

The endometrium was identified as a particularly promising novel source of MSCs for clinical applications in horses - and likely in other species too.

MSCs obtained from bone marrow or adipose tissue have been used for clinical tissue regeneration in animals for more than 10 years, which scientists say assures their safe use as potential clinical antimicrobials in the future.

Lead author Dr Cristina Esteves said: “This study shows that equine MSCs may act to defend the body against bacterial infection.

"We’re excited about these results as MSCs could prove useful against antimicrobial resistance and be used as an alternative to antibiotics.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.